Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AGIO | AGIOS PHARMACEUTICALS, INC. | Chief Executive Officer, Director | $7.76M | -$1.64M | -17.5% | Aug 8, 2024 |
NTLA | Intellia Therapeutics, Inc. | Director | $508K | Jun 13, 2024 | ||
ALXN | ALEXION PHARMACEUTICALS, INC. | EVP & Chief Commercial Officer | Jul 21, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|